Pcn162 - Denosumab Versus Bisphosphonates for the Treatment of Bone Metastases From Solid Tumors: A Systematic Review of Economic Studies

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.245
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Role of Denosumab in the Management of Skeletal Complications in Patients With Bone Metastases From Solid Tumors

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Denosumab Versus Bisphosphonates in Patients With Advanced Cancers-Related Bone Metastasis: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Supportive Care in Cancer
Oncology
2018English

Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients With Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

High Serum ALP Level Is Associated With Increased Risk of Denosumab-Related Hypocalcemia in Patients With Bone Metastases From Solid Tumors

Endocrine Journal
EndocrinologyMetabolismDiabetes
2016English

Bisphosphonates and Bone Metastases

British Journal of Cancer
Cancer ResearchOncology
1988English

Denosumab in the Treatment of Glucocorticoid-Induced Osteoporosis: A Systematic Review and Meta-Analysis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Economic Evaluation of Antipsychotics for the Treatment of Schizophrenia: A Systematic Review

Jornal Brasileiro de Economia da Saúde
2017English

Economic Evaluation of Denosumab Compared With Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients With Bone Metastases

Journal of Managed Care Pharmacy
2011English

Strategies for Treatment of Bone Metastases From Breast Cancer

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy